Ledger.Open graph →
SEC Form D · filed August 25, 2017

Carmot Therapeutics Inc

Offering
$15.4M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Daniel A. Erlanson · San Francisco, CAExec · DirectorStig K. Hansen · San Francisco, CAExec · DirectorJames A. Huang · Warrington, PADirectorMark H. Handfelt · Seattle, WADirectorJames T. Hayhurst · SAANICHTON, British Columbia, CanadaExec · DirectorRichard Shipley · POWELL RIVER, British Columbia, CanadaExec · DirectorAetna W. Trombley · San Francisco, CADirectorLarry K. Lasky · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗